Merck remains a top Big Pharma name with strong leadership, rising sales, and high margins, despite regulatory fears and ...

Pfizer has terminated a Phase II study of its CD47 immune checkpoint inhibitor, maplirpacept, due to low recruitment. In an ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

The UK’s medical research charity LifeArc has received a windfall of nearly $1.3 billion after selling a portion of its royalty interest in Merck & Co’s blockbuster cancer drug Keytruda to a ...

Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copySouth Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster ...

As drug development increasingly targets multiple indications, pharma companies must make strategic branding ...

Bill Gates warns that continued U.S. cuts to global health aid could result in 8 million additional child deaths by 2040, urging Congress to reverse course and restore funding to critical programs ...

Johnson & Johnson is a pharmaceutical and medical device company. Its two primary business segments are Innovative Medicine, which develops and markets prescription drugs, and MedTech, which ...

What Triggered the Stock Surge: The company expanded rapidly into weight loss programs, launching GLP-1 medication access and ...